Results 241 to 250 of about 99,677 (264)
Some of the next articles are maybe not open access.

Tocilizumab

Reactions Weekly, 2015
  +6 more sources

Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia

New England Journal of Medicine, 2021
Ivan O Rosas   +2 more
exaly  

Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia

New England Journal of Medicine, 2021
Reena Shah
exaly  

Tocilizumab

Reactions Weekly, 2022
openaire   +2 more sources

Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial

Lancet, The, 2021
Frances Humby   +2 more
exaly  

Efficacy of Tocilizumab in Patients Hospitalized with Covid-19

New England Journal of Medicine, 2020
John H Stone   +2 more
exaly  

Tocilizumab in COVID-19 therapy: who benefits, and how? – Authors' reply

Lancet, The, 2021
Peter W Horby   +2 more
exaly  

Tocilizumab

Reactions Weekly
  +4 more sources

Tocilizumab

Reactions Weekly, 2016
openaire   +2 more sources

Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial

Nature Medicine, 2022
Felice Rivellese   +2 more
exaly  
covid-19
medicine
interleukin-6
cytokine storm
cytokine release syndrome
rheumatoid arthritis
critical care
mortality
previous   23  24  25  26  27  

Home - About - Disclaimer - Privacy